Form 4: Labcorp EVP nets shares from performance award

Labcorp EVP/CIO/CTO Akinbolade Oyegunwa received 1,340 shares from a 2023 performance award and netted 958 shares after tax withholding.

Summary

• On March 26, 2026, EVP, CIO & CTO Akinbolade Oyegunwa acquired 1,340 Labcorp common shares at no cost pursuant to a performance award granted on February 7, 2023 covering the three-year period ended December 31, 2025.
• To satisfy tax obligations, 382 shares were withheld at $268.38 per share.
• Net increase in beneficial ownership was 958 shares, resulting in 5,064.253 shares held directly after the transactions.
• All reported holdings are direct; there were no open-market purchases or sales beyond tax withholding.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mildly positive, routine insider equity delivery that increases executive alignment without signaling major changes to fundamentals.

Positives

• Performance-based equity converted into 1,340 shares, reflecting completion of the three-year performance period (ending December 31, 2025).
• Executive’s net ownership increased by 958 shares, with ending direct holdings of 5,064.253 shares.
• No discretionary sales were reported; only tax withholding occurred.

Negatives

• Tax withholding reduced the gross award by 382 shares at $268.38 per share.
• No detail provided on payout level versus target (e.g., below, at, or above target).

Future Outlook

No forward-looking statements or guidance provided.

Industry Context

StockSavvy.ai notes that routine vesting and delivery of performance share units with standard tax withholding mirrors common practice among healthcare diagnostics peers and is typically non-directional for fundamentals.

Comparison to Industry Standards

• Comparable to Quest Diagnostics (DGX) and IQVIA (IQV) executive equity programs that use three-year performance share units with delivery upon certification and share withholding for taxes.
• Absence of discretionary open-market selling is common in similar insider transactions and does not, on its own, imply a bullish or bearish stance.
• Use of direct ownership reporting aligns with standard governance disclosures for U.S.-listed healthcare companies.

Stakeholder Impact

• Executive ownership increased to 5,064.253 shares, modestly strengthening alignment with shareholders.
• Only tax withholding occurred; no open-market selling that might signal sentiment.
• Operational and customer relationships remain unaffected; this is an administrative equity event.

Key Dates

Keywords

Labcorp, LH, insider transaction, Form 4, performance award, equity compensation, executive officer, stock withholding, beneficial ownership, Akinbolade Oyegunwa